Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.79 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6248152 | 1.00 | HSD17B10 (0.79) | HSD17B10 | |
| Ethylene SCHEMBL11522064 | 0.89 | HSD17B10 (0.92) | HSD17B10 | |
| SCHEMBL31490441 | 0.89 | — | — | |
| SCHEMBL18277428 | 0.89 | — | — | |
| Propene SCHEMBL16439952 | 0.87 | HSD17B10 (0.88) | HSD17B10 | |
| Iodide SCHEMBL11882843 | 0.87 | HSD17B10 (0.96) | HSD17B10 | |
| Butadiene SCHEMBL10731965 | 0.85 | HSD17B10 (0.85) | HSD17B10 | |
| Propene SCHEMBL1661040 | 0.85 | HSD17B10 (0.85) | HSD17B10 | |
| Propene SCHEMBL2322954 | 0.85 | HSD17B10 (0.85) | HSD17B10 | |
| Propene SCHEMBL1022915 | 0.85 | HSD17B10 (0.85) | HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 84 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11767376-B2 | Catalyst mixture | ARLANXEO NETHERLANDS B.V. (NL) | 2023-09-26 | — | — | US | claimed |
| US-11578148-B2 | Metal complex comprising amidine and thiophene fused cyclopentadienyl ligands | ARLANXEO NETHERLANDS B.V. | 2023-02-14 | — | — | US | claimed |
| US-20220056162-A1 | CATALYST MIXTURE | ARLANXEO NETHERLANDS B.V. (NL) | 2022-02-24 | — | — | US | claimed |
| EP-3732183-B1 | METAL COMPLEX COMPRISING AMIDINE AND THIOPHENE FUSED CYCLOPENTADIENYL LIGANDS | Arlanxeo Netherlands Bv (NL) | 2021-10-20 | — | — | EP | claimed |
| EP-3853265-A1 | CATALYST MIXTURE | Arlanxeo Netherlands B.V. (NL) | 2021-07-28 | — | — | EP | claimed |
| US-20210087305-A1 | METAL COMPLEX COMPRISING AMIDINE AND THIOPHENE FUSED CYCLOPENTADIENYL LIGANDS | ARLANXEO NETHERLANDS B.V. (NL) | 2021-03-25 | — | — | US | claimed |
| EP-3781582-A1 | METAL COMPLEX COMPRISING AMIDINE AND INDOLE FUSED CYCLOPENTADIENYL LIGANDS | Arlanxeo Netherlands B.V. (NL) | 2021-02-24 | — | — | EP | claimed |
| EP-3732183-A1 | METAL COMPLEX COMPRISING AMIDINE AND THIOPHENE FUSED CYCLOPENTADIENYL LIGANDS | Arlanxeo Netherlands B.V. (NL) | 2020-11-04 | — | — | EP | claimed |
| EP-2857423-B1 | Catalyst system | Arlanxeo Netherlands Bv (NL) | 2020-09-16 | — | — | EP | claimed |
| EP-3334768-B1 | CATALYST SYSTEM | Arlanxeo Netherlands Bv (NL) | 2020-05-27 | — | — | EP | claimed |
| US-20160115265-A1 | METAL COMPLEX WITH A LEWIS BASE LIGAND | THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD (GB) | 2016-04-28 | — | — | US | claimed |
| EP-2816050-B1 | Bimetallic complex comprising cyclopentadienyl and amidine ligands | LANXESS ELASTOMERS BV (NL) | 2016-04-27 | — | — | EP | claimed |
| WO-2016041818-A1 | METAL COMPLEX COMPRISING AMIDINE AND SUBSTITUTED CYCLOPENTADIENYL LIGANDS | LANXESS ELASTOMERS B.V. (NL) | 2016-03-24 | — | — | WO | claimed |
| WO-2015052184-A1 | CATALYST SYSTEM | LANXESS ELASTOMERS B.V. (NL) | 2015-04-16 | — | — | WO | claimed |
| EP-2857423-A1 | Catalyst system | Lanxess Elastomers B.V. (NL) | 2015-04-08 | — | — | EP | claimed |
| EP-2816050-A1 | Bimetallic complex comprising cyclopentadienyl and amidine ligands | Lanxess Elastomers B.V. (NL) | 2014-12-24 | — | — | EP | claimed |
| WO-2014202644-A1 | BIMETALLIC COMPLEX COMPRISING CYCLOPENTADIENYL AND AMIDINE LIGANDS | LANXESS ELASTOMERS B.V. (NL) | 2014-12-24 | — | — | WO | claimed |
| EP-2801578-A1 | Metal complex with a bridged cyclopentadienyl amidine ligand | Lanxess Elastomers B.V. (NL) | 2014-11-12 | — | — | EP | claimed |
| EP-2801579-A1 | Metal complex with a Lewis base ligand | Lanxess Elastomers B.V. (NL) | 2014-11-12 | — | — | EP | claimed |
| US-7713539-B2 | Medical devices containing radiation resistant block copolymer | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2010-05-11 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210087305-A1 | METAL COMPLEX COMPRISING AMIDINE AND THIOPHENE FUSED CYCLOPENTADIENYL LIGANDS | AP3M1, AP2M1, AP1M1 | HSD17B10 4671/4885 |
| US-20160115265-A1 | METAL COMPLEX WITH A LEWIS BASE LIGAND | CD81, LETM1, ANTXR2 | HSD17B10 3961/4885 |
| US-11578148-B2 | Metal complex comprising amidine and thiophene fused cyclopentadienyl ligands | AP3M1, AP2M1, AP1M1 | HSD17B10 4671/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.